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INTRODUCTION
The clinical importance of chemical determinations
in saliva is increasing. They have been used for
assessing endocrine functions (1), for monitoring
drug concentrations (2), for measuring antibodies
and antigens (3), and for dynamic diagnostic tests
(4).
Saliva may be obtained separately from each pair
of glands such as parotid (5, 6), submaxillary / sub-
lingual (7, 8), palatine (9), and smaller glands (10),
but these techniques should be performed by spe-
cialized technicians. Besides, because the
participation of each group of glands in the compo-
sition of whole saliva is very variable, the study of
whole saliva is now preferred (11).
Four collection methods have been devised to meas-
ure resting whole saliva: draining, spitting, suction
and swab (with cotton rolls or filter paper). They
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The present study describes a methodology to assess the sali-
vary flow rate in humans. Whole saliva was obtained from the
floor of the mouth with a plastic dental ejector and a vacuum
pump. 
Forty healthy subjects of both sexes and 51 patients with differ-
ent pathologies (Sjögren Syndrome, Thyroid Dysfunction,
Diabetes Mellitus) were included in the study.
It was demonstrated that basal salivary flow rate was stable
five minutes after the insertion of the oral ejector. Salivary flow
rate did not show significant differences between sexes and was
independent of the negative pressure level of the vacuum pump.
Stimulated salivary flow rate was quantified over a period of 3
minutes, starting 5 minutes after the introduction of the oral
device. The stimulus was paper filter disks soaked in citric acid
(2%) placed on the tongue dorsum. 
The use of this method confirmed the reduction of salivary flow
rate in patients with Sjögren Syndrome. In addition, a signifi-
cant reduction in salivary flow rate was observed in patients
with primary thyroid insufficiency and peripheral neuropathy
secondary to Diabetes Mellitus.
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RESUMEN
En este trabajo se describe la normatización de un método para
determinar flujo salival en humanos utilizando saliva total
obtenida del piso de la boca mediante un eyector dental des-
cartable y una bomba de vacío (equipo dental).
En este estudio se evaluaron 40 sujetos sanos de ambos sexos y
51 pacientes con diversas patologías (Síndrome de Sjögren,
Disfunción Tiroidea, Diabetes Mellitus). 
Se demostró que el flujo salival basal era estable a partir de los
primeros 5 minutos de colocado el eyector en la cavidad bucal.
No se encontraron diferencias significativas en el flujo salival
basal comparando los sexos, siendo independiente de la inten-
sidad del vacío efectuado por la bomba. El flujo de saliva total
estimulada fue determinado durante 3 minutos, luego de los pri-
meros 5 minutos de colocado el eyector en la boca. El estímulo
se efectuó adosando en la cara dorsal de la lengua discos de
papel absorbente, embebidos en ácido cítrico al 2 %. 
El uso de este método en pacientes con Síndrome de Sjögren
confirmó la reducción del flujo salival respecto a los sujetos
sanos. Los pacientes hipotiroideos y con neuropatía diabética
demostraron disminución del flujo salival. 
Palabras Clave: Saliva Total, Sialometría, Sialoquímica, Sín-
drome de Sjögren, Hipotiroidismo, Diabetes Mellitus.
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are considered to be equivalent (11). Gustatory or
masticatory stimuli are used to stimulate the sali-
vary flow (11). The aim of this paper was to
describe a simple, accurate and reliable method to
collect resting and stimulated saliva in order to
detect changes in whole saliva composition second-
ary to primary systemic disease.
MATERIALS AND METHODS
Whole saliva was obtained from the floor of the
mouth using a plastic dental saliva ejector tip (a),
attached via plastic tubing (b) to a vacuum pump
(c). Saliva was collected in a graduated centrifuge
tube (d) as shown in Figure 1. This methodology,
based on Navazesh and Christman (11), was
designed for easy application in hospitalized and
ambulatory patients. 
Saliva was collected from 40 healthy subjects (10
males and 10 females; 35 ± 15 years old). They
were non-smokers and were off alcohol and drugs.
Resting whole saliva was obtained in basal condi-
tions between 8:00 and 9:00 a.m., in order to
minimize changes due to circadian variations.
Before the extraction of saliva the subjects rinsed
their mouth twice with tap water to remove food
debris and other non salivary elements that could
interfere with measurements.
Stimulated whole saliva was measured the next day.
It was collected during a 3-minute period, 5 min-
utes after the insertion of the ejector tip in the
mouth. The stimulus consisted of 3 Whatman filter
paper disks, 18 mm in diameter, soaked in citric acid
(2%), placed on the tongue dorsum for one minute
each.
Study design
a) Optimal time interval for saliva collection
Resting whole saliva was obtained from the 40 con-
trol subjects, over a 15-minute period, at one-minute
intervals. 
b) Influence of different negative pressures of the
vacuum pump on saliva collection
Six control subjects were selected, 3 with high sali-
va resting flow rates and 3 with low saliva resting
flow rates. The extraction of saliva was performed
at different negative pressures of the vacuum pump
(8, 10, 14, 17, 20 and 23 mm Hg). 
c) Reproducibility of the results
Resting whole saliva samples were obtained daily
for 10 days from 10 control subjects. 
d) Storage conditions and sialochemistry
The samples obtained from healthy subjects were
centrifuged and the supernatant was divided in two
parts. One was immediately frozen and kept for 30
days at -22 ºC until assays were performed. The
other was kept at room temperature and processed
within 30 minutes. Total proteins, amylase activity,
chloride, calcium, sodium and potassium were
assessed in all salivary samples as described (12,
13, 14, 15).
e) Clinical application
The study group consisted of 51 patients, 13 with
thyroid disease, 25 with Diabetes
Mellitus and 13 with Sjögren Syndrome. 
Of the thirteen female patients with thyroid disease
(aged 45 ± 20 years), six patients had primary
hypothyroidism (HT-) and seven had hyperthy-
roidism (HT+).
Of the twenty-five patients with Diabetes Mellitus
(9 women and 16 men; aged 25 ± 8 years), eighteen
had Diabetes Mellitus without neuropathy (DM N_),
and seven had Diabetes Mellitus with neuropathy
(DM N+).
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Fig 1: Saliva collection device:
its components.
a) plastic dental saliva ejector tip;
b) plastic connecting tube;
c) vacuum pump;
d) graduated centrifuge tube.
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The thirteen patients with
Sjögren Syndrome (SS1)
(aged 50 ± 15 years), were
diagnosed by biopsy grade 4
as described by Greenspan et
al. (16). Nine had associated
rheumatoid arthritis (SS2).
Statistical methods
The results were expressed as
mean ± SEM. The data were
analyzed by ANOVA. When
the hypothesis of the equali-
ty of the means was rejected,
Student-Newman–Keuls test
was employed (17). A value
of p < 0.05 was considered
significant.
RESULTS
The resting whole saliva
flow rates obtained every
minute for 15 minutes in 40
healthy subjects are shown in
Figure 2. Resting salivary
flow rates were significantly
different (p < 0.05) between
Group 1 (1 and 4 minutes of collection) and Group
2 (from 5 to 15 minutes of collection). These differ-
ences were unrelated to gender.
Whole saliva flow rates stimulated by citric acid did
not show differences between males (1.56 ± 0.33
ml/min) and females (1.57 ± 0.58 ml/min).
Table I shows the saliva volumes obtained over a 5
minute period (5 to 10 minutes after saliva collec-
tion began). Volumes were independent of variation
in negative pressure of the vacuum pump and of
variations in basal flow rate high (>0.28 ml/min) or
low (< 0.28 ml/min). 
Table II shows that whole saliva resting flow rate
did not change in healthy subjects over a 10-day
period.
Table III shows salivary levels of total proteins,
amylase activity, sodium, potassium, chloride and
calcium. No significant differences were found as a
result of freezing the samples.
Resting and stimulated whole saliva flow rates of
patients are displayed in Table IV. No difference
was found between DM N  patients and controls.
DM N+ patients showed a significant reduction in
the stimulated flow rates (p < 0.001).
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VACUUM PUMP PRESURE (mm Hg) HIGH FLOW RATE (ml/min) LOW FLOW RATE (ml/min)
8 0.305 ± 0.003 0.253 ± 0.015
10 0.306 + 0.003 0.254 ± 0.006
14 0.306 ± 0.004 0.255 ± 0.007
17 0.311 ± 0.005 0.263 ± 0.014
20 0.295 ± 0.008 0.253 ± 0.018
23 0.307 ± 0.001 0.269 ± 0.004
Salivary flow rates were independent of the vacuum pump pressure 
TABLE I. Effects of vacuum pump pressure on whole saliva resting flow rate in healthy subjects
with high salivary flow rate (> 0.28 ml/min) or low salivary flow rate (< 0.28 ml/min)
Fig 2: Basal whole salivary flow rate in 40 healthy subjects obtained over a fifteen minute
period (20 males •-• and 20 females ■ -■). 
Salivary flow-rate obtained from minutes 1 to 4 (group 1) was unstable and significantly
lower (p < 0.0001) than after 5 minutes (group 2).
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Patients with hypothyroidism exhibited a signifi-
cant reduction in resting (p < 0.05) and stimulated
(p < 0.01) flow rates compared to healthy subjects.
No differences were found between patients with
hyperthyroidism and controls.
A decrease in resting (p < 0.05) and stimulated sali-
vary flow rate (p < 0.001) was confirmed in patients
with Sjögren Syndrome. No difference was found
between SS1 and SS2 patients. 
DISCUSSION
This study shows a simple and practical method to
measure whole saliva flow-rate in humans. The equip-
ment is easily obtainable, as it can be found in dental
offices and clinical laboratories. The samples should
be collected five minutes after the introduction of the
oral device to obtain stable salivary flow rates. At this
time, values were accurate and independent of the
intensity of suction of the vacuum pump. 
This method is useful for sialochemistry assays.
Saliva samples should be centrifuged and the super-
natant used to determine electrolytes, amylase
activity and proteins. Freezing of the samples for
30 days did not alter the results.
Salivary flow rate evaluates acinar gland function
and is useful for the study of functional gland
integrity in different clinical disorders. It is known
that salivary flow rates are decreased in Sjögren
Syndrome (18, 19, 20, 21) and using the methodol-
ogy proposed we reconfirmed this finding Diabetic
patients did not show changes in whole saliva rest-
ing or stimulated flow rates. However, this finding
is still controversial (22, 23, 24, 25). The decrease
in whole saliva flow-rates in diabetic patients is sug-
gestive of neuropathy and it has been proposed that
this finding contributes to the diagnostic suspicion
of this neurological complication (26, 27). The sali-
va flow rates are decreased in hypothyroid, but not
in hyperthyroid patients. These findings are in keep-
ing with studies on experimental models that
revealed that thyroid hormones modulate the effects
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SUBJECT FLOW RATE (ml/min)
A 0.26 ± 0.01
B 0.27 ± 0.01
C 0.27 ± 0.01
D 0.26 ± 0.01
E 0.27 ± 0.01
F 0.28 ± 0.01
G 0.23 ± 0.01
H 0.27 ± 0.01
I 0.27 ± 0.01
J 0.29 ± 0.01
Salivary flow rates are expressed as mean ± SE.
Variability of salivary flow-rates in healthy subjects was not
significant.
TABLE II. Whole saliva flow rates of 10 subjects
measured during 10 consecutive days
Unfrozen samples Frozen samples
Protein (mg %) 228 ± 21.30 210 ± 19.90 
Amylase (UA) 252 ± 27.60 335 ± 21.90 
Na++ (mEq/l) 3.75 ± 0.79 3.80 ± 0.80
Ca++ (mEq/l) 2.22 ± 0.21 2.35 ± 0.40
K+ (mEq/l) 21.3 ± 0.55 22.3 ± 0.40
Cl - (mEq/l) 19.8 ± 2.80 20.0 ± 1.00
After centrifugation the supernatant of saliva samples was
divided in two parts: one part was processed within 30 min-
utes (unfrozen) and the other was stored at -22 ºC during 30
days until processing (frozen). 
Levels of protein, amylase activity and electrolytes were
measured in supernatants of saliva samples. All values were
expressed as mean ± SE. 
No significant differences were found between frozen and
unfrozen samples.
TABLE III. Storage conditions 
and sialochemistry.
FLOW RATE SJOGREN PATIENTS THYROID PATIENTS DIABETIC PATIENTS
(ml/min) SS1 SS2 HT(+) HT(-) DM N- DM N+
Basal 0.07 ± 0.04* 0.10 ± 0.04* 0.30 ± 0.03 0.11 ± 0.04* 0.23 ± 0.03 0.17 ± 0.04
Stimulated 0.38 ± 0.15* 0.43 ± 0.16* 1.75 ± 0.31 0.78 ± 0.28* 1.47 ± 0.12 0.97 ± 0.23* 
Flow-rate (ml/min) is expressed as mean ± SEM 
SS1: patients with Sjögren Syndrome; SS2: patients with Sjögren Syndrome and associated Rheumatoid Arthritis.
Patients with primary Hypothyroidism (HT-): and Hyperthyroidism (HT+):
Patients with Diabetes Mellitus without neuropathy (DM N-) and with neuropathy (DM N+).
Healthy subjects: basal flow rate: 0.27 ± 0.02 ml/min; stimulated flow rate: 1.54 ± 0.12 ml/min
* P< 0.05 patients compared with healthy subjects
TABLE IV. Basal and stimulated whole saliva flow rate in patients with several pathologies.
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of autonomic drugs and neurotransmitters on sali-
vary glands (28, 29, 30).
This study reveals that the method proposed is a
useful tool that contributes to the diagnostic
approach to systemic diseases. Further studies
should be considered to extend the diagnostic
importance of this non-invasive methodology to
other areas of internal medicine.
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